author-photo

M. López-Brea

92

Papers

2186

Citations

Citation Trend

Filter By

Papers (65) Sort By

Journal Conference Others

18O CC-90011 in patients (Pts) with advanced solid tumors (STs) and relapsed/refractory non-Hodgkin lymphoma (R/R NHL): Updated results of a phase I study

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Randomised phase II study comparing alternating cycles of sunitinib and everolimus versus standard sequential administration in first‐line metastatic renal carcinoma (SUNRISES study)

2020 BJUI
Show All
- Source
- Cite
- Save
Citations (0)
Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Non-Small Cell Lung Carcinoma Patients: the ROSING Study

2019 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (34)
P1.09-09 Evaluation of a Novel ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in NSCLC Patients

2018 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Consensus Recommendations from the Spanish Germ Cell Cancer Group on the Use of High-dose Chemotherapy in Germ Cell Cancer

2017 European urology focus
Show All
- Source
- Cite
- Save
Citations (2)
Phase II trial of cabazitaxel in patients with advanced or metastatic transitional cell carcinoma of the urothelial tract who have progressed within less than 12 months after cisplatin-based chemotherapy: A Spanish Oncology Genitourinary Group (SOGUG) study.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
MA 15.01 LungBEAM: A Prospective Multicenter Trial to Monitor EGFR Mutations Using BEAMing Technology in Stage IV NSCLC Patients

2017 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Validation of the International Metastatic Renal-Cell Carcinoma Database Consortium (IMDC) prognostic model for first-line pazopanib in metastatic renal carcinoma: the Spanish Oncologic Genitourinary Group (SOGUG) SPAZO study

2016 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (26)
2602 Pazopanib (Pz) as first line for metastatic renal carcinoma (mRC): Updated validation of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model (IMRCC). The SPAZO study (SOGUG)

2015 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG)

2014 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (73)